Clinical Trials in Georgia

Showing 17261-17280 of 19,050 trials

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

NCT01703793

The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.

Seborrheic Dermatitis

Medicis Global Service Corporation240 participantsStarted Sep 2012

Fremont, California, United States • Los Angeles, California, United States • San Diego, California, United States +19 more locations

COMPLETEDPhase 363 miles

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385

This is a comparative study of CP 690,550, Humira (adalimumab) and placebo on background methotrexate in patients with Rheumatoid Arthritis. The study is intended to provide evidence of the efficacy and safety of CP 690,550 when dosed 5 mg and 10 mg twice a day on background methotrexate in adult patients with moderate to severe Rheumatoid Arthritis. It is intended to confirm the benefits of CP-690,550 in improving signs and symptoms and physical function that were observed in Rheumatoid Arthritis. An active comparator, adalimumab, is also included.

Rheumatoid Arthritis

Pfizer717 participantsStarted May 2009

Gilbert, Arizona, United States • Glendale, Arizona, United States • Mesa, Arizona, United States +122 more locations

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

Find Trials by Condition in Georgia

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Prenatal Test for Fetal Aneuploidy Detection

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Rollover Protocol for Prior SU011248 Protocols

Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis

Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

A Study of Econazole Foam 1% in Athlete's Foot

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

Effects of Acleara Needle Insert on Acne

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia